Oncology Today with Dr Neil Love cover image

The Implications of New Research Findings for the Management of Endometrial Cancer

Oncology Today with Dr Neil Love

00:00

The Importance of HER2 in Metastatic Endometrial Cancer

There's a consensus that people with metastatic endometrial cancer need, a biomarker, workup. Investigators generally use an NGS and certainly IHC is an option. And HER2, I think, after what we just heard, I think is even more important. We're getting down to our last two weeks estimated supply of carbo at Percibel. But we do have now developed plans for the use of axialoplatin as you see across here.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app